Inventor · disambiguated record
Arwel Lewis
Also filed as: LEWIS ARWEL
6 granted patents·5 pending applications·22 citations·filing 2015–2024
78Inventor score
Top patents by PatentIndex Score
11 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0292US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0392US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0485US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 0582US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0670US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 0767US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0860US2024150321A1Pyrazolylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0960US2024150365A1Pyridinylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1047US2018289718A1Fused imidazole compoundsONO PHARMACEUTICAL CO·Filed 2018·Application pending·0 cites
- 1139US10016439B2Fused imidazole compoundsONO PHARMACEUTICAL CO·Filed 2015·Granted Jul 10, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Arwel Lewis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →